Scan­dal-prone Sub­sys mak­er In­sys falls as au­di­tor flags go­ing con­cern doubt

Af­ter hir­ing Lazard in the fourth quar­ter for coun­sel on cap­i­tal plan­ning and strate­gic al­ter­na­tives, the au­di­tor of the con­tro­ver­sial opi­oid painkiller mak­er In­sys Ther­a­peu­tics …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER